Takahiro Ochiya

Spezialisierung: Präventivmediziner
Arbeitsplatz: Japan, Osaka, CELL GRAND CLINIC
- Specialist at the clinic: academic collaboration with Professor Takahiro Ochiya (Tokyo Medical University) informs the clinic’s exosome protocols through decades of extracellular vesicle (EV) research.
- Professor Takahiro Ochiya previously led the Division of Molecular and Cellular Medicine at the National Cancer Center Research Institute in Tokyo.
- He is a recipient of the Princess Takamatsu Cancer Research Prize for pioneering work on microRNA and extracellular vesicle signaling.
- His research focus centers on exosome biology and extracellular vesicle (EV) signaling pathways, including microRNA signaling.
As a specialist at the clinic, Professor Takahiro Ochiya’s exosome and extracellular vesicle research directly shapes the clinic’s exosome protocols. His work focuses on microRNA and EV signaling, with collaboration rooted in his decades of EV expertise. He has also led molecular and cellular research at the National Cancer Center Research Institute in Tokyo and received the Princess Takamatsu Cancer Research Prize.

Wie läuft es für Sie mit uns?

1 von 3

Die Informationen über diesen Arzt sind vollständig und klar

Stimme nicht zu

Stimme stark zu

Qualifikationen

Professor Takahiro Ochiya’s work on microRNA and extracellular vesicle signaling is the scientific backbone behind the clinic’s exosome protocols. At the clinic, the exosome program is supported by an academic collaboration with Professor Ochiya, who serves at the Institute of Medical Science, Tokyo Medical University. His prior leadership includes heading the Division of Molecular and Cellular Medicine at the National Cancer Center Research Institute in Tokyo. The collaboration is positioned as a way to translate EV research depth into practical cultivation and protocol decisions for regenerative treatments.

Education

Institute of Medical Science, Tokyo Medical University — academic role (programme and years not specified in the clinic materials).

Work experience

Institute of Medical Science, Tokyo Medical University — Professor (current role mentioned).
National Cancer Center Research Institute, Tokyo — Division of Molecular and Cellular Medicine (previously led the division).

Clinical focus and techniques

Professor Ochiya’s contribution is research-driven: the clinic’s exosome protocols are described as being informed by his expertise in how extracellular vesicles carry biological signals.

Exosome biology and extracellular vesicle (EV) signaling — research focus used to guide protocol development.
MicroRNA and extracellular vesicle signaling — highlighted as a core area of his pioneering work.

Awards and recognition

Princess Takamatsu Cancer Research Prize — recipient (year not specified in the clinic materials).

Professional societies and certifications

Academic output

Professor Ochiya is described in the clinic collaboration materials as a leading authority on extracellular vesicles and exosome biology.

Courses and advanced training

For patients, the practical value of this collaboration is that the clinic’s exosome protocols are presented as being informed by decades of EV research. The clinic’s regenerative medicine pathway is delivered in Osaka, Japan, with international coordination supported through the clinic’s international patient process. Communication and treatment planning are handled through the clinic’s established international workflow.